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Abstract
Mammalian telomeres stabilize chromosome ends as a result of their assembly into a peculiar form of chromatin comprising
a complex of non-histone proteins named shelterin. TRF2, one of the shelterin components, binds to the duplex part of
telomeric DNA and is essential to fold the telomeric chromatin into a protective cap. Although most of the human telomeric
DNA is organized into tightly spaced nucleosomes, their role in telomere protection and how they interplay with telomere-
specific factors in telomere organization is still unclear. In this study we investigated whether TRF2 can regulate nucleosome
assembly at telomeres. By means of chromatin immunoprecipitation (ChIP) and Micrococcal Nuclease (MNase) mapping
assay, we found that the density of telomeric nucleosomes in human cells was inversely proportional to the dosage of TRF2
at telomeres. This effect was not observed in the G1 phase of the cell cycle but appeared coincident of late or post-
replicative events. Moreover, we showed that TRF2 overexpression altered nucleosome spacing at telomeres increasing
internucleosomal distance. By means of an in vitro nucleosome assembly system containing purified histones and
remodeling factors, we reproduced the short nucleosome spacing found in telomeric chromatin. Importantly, when in vitro
assembly was performed in the presence of purified TRF2, nucleosome spacing on a telomeric DNA template increased, in
agreement with in vivo MNase mapping. Our results demonstrate that TRF2 negatively regulates the number of
nucleosomes at human telomeres by a cell cycle-dependent mechanism that alters internucleosomal distance. These
findings raise the intriguing possibility that telomere protection is mediated, at least in part, by the TRF2-dependent
regulation of nucleosome organization.
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Introduction
Telomeres are an important genome-stabilizing component of
linear chromosomes. Variations in telomere status critically affect
cell senescence, stem cell biology, and the development of many
diseases, including cancer [1]. The importance of telomeres in
governing cell fate is likely attributable to their numerous
functions; they protect chromosome ends from DNA damage
checkpoint machinery and repair, control the terminal replication
of chromosomal DNA, localize chromosome ends within the
nuclear space, and regulate gene expression [2,3].
In most organisms, telomeres are composed of short, tandemly
repeated DNA sequences, ending in a G-rich single-stranded 39
tail. They are transcribed in a G-rich RNA named TERRA [4],
which is thought to play relevant functions at telomeres. The
chromatin structure of telomeres is unusual, forming a so-called
telosome [5,6]. Telosomes are essential for the preservation of
chromosome stability; they control telomere length, recombina-
tion, and DNA damage checkpoints. The yeast telosome is a non-
nucleosomal chromatin structure containing the telomeric DNA-
binding protein Rap1p [7]. A key component of human telosomes
is the shelterin complex [8,9], a structure composed of six
polypeptides (TRF1, TRF2, RAP1, Tin2, TPP1, and Pot1). Three
of the shelterin components recognize directly telomeric DNA;
TRF1 and TRF2 bind telomeric DNA duplexes, while Pot1 binds
single-stranded 39 overhangs. In contrast to yeast telomeric
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organization, the shelterin complex appears to co-localize with
nucleosomes. In higher eukaryotes, most telomeric DNA is
organized into tightly spaced nucleosomes [10–13]; moreover, a
30-nm telomeric fibre has been observed in the telomeres of
chicken erythrocytes and of quiescent mouse lymphocytes [14].
Mammalian telomeric chromatin exhibits characteristics of
heterochromatin [15] and triggers telomere position effects
[16,17]. Other links between telomeres and chromatin include
the ATRX-dependent enrichment of the histone variant H3.3 at
telomeres [18,19] and the phosphorylation of the H2AX histone
triggered by dysfunctional telomeres [20]. Furthermore, telomere
shortening negatively affects histone synthesis, probably via
damage signal induction [21]. Overall, it appears that the
particular nature of telomeric chromatin plays a role in telomere
capping, telomere length regulation, and long-range gene
expression.
However, an unresolved question regarding the organization of
mammalian telosomes is whether nucleosomes and components of
the shelterin complex occupy different portions of the telomere, or
whether they co-localize and cooperate to establish a protective
telomere structure [22]. Indeed, the repeated nature of the
telomeric DNA sequence suggests that the tight spacing of
telomeric nucleosomes revealed by micrococcal nuclease (MNase)
digestion could reflect the organization of only a portion of the
telomere. One must also consider that if nucleosomes were
uniformly spaced along the entire telomere, the binding of TRF1
or TRF2 would be limited to the short linker DNA or to
nucleosomal binding sites. Thus, whether specific telomeric
proteins compete with histone octamers for binding to telomeric
sequences or cooperate to form a telomeric protective structure is
still not well understood. Recent studies produced seemingly
contradictory results. Overexpression of TRF2 in primary
keratinocytes derived from transgenic mice increases histone
spacing [23], while a loss of TRF2 expression in mouse embryonic
fibroblasts did not alter nucleosome positioning [24]. This
discrepancy might be due to differences in the cell systems
utilized, since the effects of modulating TRF2 expression on
telomere length and stability can be highly cell line-dependent
[25,26]. For example, the nucleosome reduction observed upon
TRF2 overexpression [23] could be a consequence of the
extremely short telomeres characteristic of the used cells [27] or
of the long-term effects of TRF2 overexpression.
Here, we examined the short-term effects of increasing or
decreasing TRF2 levels on nucleosome organization at human
telomeres. We found an inverse correlation between the dosage of
TRF2 in telomeres and the density of nucleosomes in a telomere-
length independent manner. Moreover, we found that the TRF2
influence on chromatin organization is regulated during the cell
cycle and can be recapitulated in vitro.
Results
TRF2 overexpression reduces nucleosome density and
increases internucleosomal distance at telomeres
To investigate the interplay between TRF2 and telomeric
chromatin, we infected human cancer cell (C33A from cervix) with
lentiviral vectors encoding TRF2 full-length or a truncated form
which lacked both the N-terminal basic domain and the telobox
Myb-like C-terminal DNA-binding domain (TRF2DBDM); this
mutant has a dominant negative activity, since it forms dimers
with TRF2 that have a reduced ability to bind telomeres [25]. In
order to observe the effect of TRF2 overexpression or depletion on
histone density at telomeres, we performed chromatin immuno-
precipitation (ChIP) assays 72 h post-infection. Figure 1A shows a
slot-blot hybridization using telomeric (Telo) and Alu repeat (Alu)
DNA probes. As previously shown, the association of TRF2 with
telomeres was increased in cells overexpressing the full-length
protein (TRF2FL) compared to control cells (infected with an
empty vector), whereas the association was decreased in cells
expressing TRF2DBDM [25]. The quantities of H3, H2A, and H2B
at telomeres were inversely related to the amount of telomere-
bound TRF2. When the filters were hybridized with an Alu probe,
the H3, H2A, and H2B signals were not modified by TRF2
expression (Figure 1B). These experiments confirm and extend
previous observations made upon long term overexpression of
TRF2 in mouse cells [23], indicating that TRF2 dosage alters
nucleosomal organization. The quantities of TRF2 and immuno-
precipitated H3 at telomeres also varied inversely in HT1080
fibrosarcoma cells in a telomere length independent manner (see
Figure S1), demonstrating that the effect of TRF2 on nucleosome
organization occurs in multiple cell types. Importantly, in contrast
to the study in mouse cells [23], the overexpression of full-length
TRF2 did not induce a change in telomere length at the time point
selected for cross-linking in our ChIP experiments (Figure S2),
showing that the influence of TRF2 on nucleosome organization
does not result from telomere shortening. However, we cannot
rule out that at least part of the increase of histone density at
telomeres upon TRF2DBDM expression was related to an increase
of DNA damage at telomeres. As previously reported [28], Figure
S2 also shows that the expression of TRF2DBDM led to a slight
telomere lengthening in C33A cells.
In order to analyze the effect of TRF2 on the spacing of
telomeric nucleosomes, we digested nuclei from control cells and
C33A cells overexpressing TRF2 with micrococcal nuclease
(MNase). Figure 2A reports nucleosomal ladders obtained by
MNase digestion hybridized with a telomeric probe (left part) and
an Alu probe (right part). Consistent with previous publications
[10–12], MNase digestion showed that telomeric nucleosomes
have a repeat size shorter than Alu nucleosomes (about 160 bp
versus 180 bp for bulk nucleosomes hybridized with the Alu DNA
probe; Figure 2A). Upon TRF2 overexpression bands in telomeric
nucleosomal ladders appear more diffuse, indicating a less regular
nucleosome spacing at telomeres. This could derive from an
increase in nucleosome spacing caused by TRF2 overexpression,
evident for fragments greater than a trinucleosome (Figure 2A).
Our data suggest that the reduced immunoprecipitation of
histones upon TRF2 overexpression might result, at least in part,
from an increased internucleosomal distance. Further support to
this interpretation comes from the quantification of the overall
hybridization signal; we measured the radioactivity signal for every
single lane and calculated the ratios of the Telo probe signals to
the corresponding Alu probe signals. Figure 2B shows the ratio
values in the case of C33A cells infected both with the empty
vector and with TRF2FL. Telo/Alu ratios have been normalized to
100 in the case of control cells. Ratio values are significantly lower
in TRF2 overexpressing cells (Figure 2B), indicating a higher
sensitivity to MNase of telomeric chromatin upon TRF2
overexpression that could derive from lower nucleosome density.
It is worth noting that decreases of the Telo/Alu ratios in TRF2FL
overexpressing cells are similar (about 75% of the control signal)
except for the samples digested with 500 U/ml MNase (about
25% of the control signal). This could reflect the hypersensitivity to
MNase of telomeric mononucleosomes [11], the main product of
the digestion at this MNase concentration. These results indicate
that the TRF2-mediated alterations of nucleosome organization
observed by ChIP cannot be merely attributed to accessibility
problems or ChIP artefacts, suggesting that TRF2 binding affects
nucleosome density.
TRF2 Controls Telomeric Nucleosome Organization
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Figure 1. Nucleosome density at human telomeres depends on TRF2 expression. (A) ChIP of C33A cells overexpressing TRF2FL or TRF2DBDM
and control C33A cells using the indicated antibodies. Slot-blots were hybridized with a labelled Telo repeat probe and an Alu probe. (B)
Quantification of the data in (A) expressed as probe/input hybridization signals. Error bars are s.d. of three independent experiments. Asterisks,
p,0.05 based on unpaired Student’s t-test.
doi:10.1371/journal.pone.0034386.g001
Figure 2. Altered nucleosome spacing at C33A telomeres. (A) Digestion of chromatin from C33A cells infected with an empty vector and
C33A cells overexpressing TRF2FL with increasing amounts of MNase. From the left: MNase digests separated on 1.5% agarose gel detected by
hybridization with Telo probe; detection of telomeric nucleosomes after hybridization with Alu probe. (B) Ratio of the overall hybridization signal of
the telomeric probe with respect to the Alu probe. Ratio values for control C33A cells have been normalized to 100. Error bars are s.d. of three
independent experiments. Asterisks, p,0.05 based on unpaired Student’s t-test.
doi:10.1371/journal.pone.0034386.g002
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Overall, ChIP and MNase chromatin analyses revealed that
TRF2 exhibits cell line-independent nucleosome reorganization
properties.
Cell-cycle regulation of TRF2-mediated telomeric
remodelling
The duplication of eukaryotic DNA requires the transient
disruption of parental nucleosomes to allow progression of the
replication fork [29]. TRF2-dependent variations in histone
density at telomeres may therefore be influenced by nucleosome
dynamics that occurs during DNA replication. To address this
possibility, we synchronized C33A cells overexpressing TRF2 at
the G1/S boundary by a double-thymidine treatment followed by
a release in fresh medium (Figure 3A). The cell cycle distribution
was examined by FACS analysis (Figure 3A). Viral infections were
performed 12 h before release. The binding of histone H3 and
TRF2 to telomeres was analyzed by ChIP (Figure 3B). In TRF2-
overexpressing cells, TRF2 levels were increased compared to
control cells at all stages of the cell cycle (G1/S, 5 h and 12 h).
This is in agreement with the rapid exchange of at least a subset of
TRF2 at telomeres [30]. Concomitantly, H3 levels were decreased
both in asynchronous control cells and in synchronized cells 12 h
post-release (i.e., at the end or shortly after S phase; Figure 3).
Importantly, in cells blocked at G1/S for twelve additional hours
(12+Th, Figure 3A), the incorporation of TRF2 did not lead to a
significant histone H3 displacement (Figure 3C). These results
show that the changes in nucleosome organization triggered by
TRF2 require both telomeric DNA binding and a cell cycle-
regulated event occurring between the end of the S and G1 phases.
TRF2 affects nucleosome organization at telomeric
sequences in vitro
We next examined the ability of TRF2 to interfere with
nucleosome assembly in vitro. It was shown previously that the
reconstitution of nucleosomal arrays by salt dilution at high
saturation levels of histone octamers allows the reproduction of the
tightly spaced organization of telomeric chromatin found in vivo,
due to the absence of nucleosome positioning signals on telomeric
DNA [31,32]. Furthermore, addition of TRF2 to reconstituted
telomeric nucleosomal arrays induces chromatin compaction
[33,34]. However, reconstitution by salt dilution does not allow
evaluating whether TRF2 competes with nucleosome assembly,
since nucleosome formation occurs at non-physiological ionic
strengths that disfavour TRF2 binding. We therefore decided to
use Drosophila embryonic extracts to assemble telomeric nucleoso-
mal arrays [35]. This method offers several advantages, one of
which being that assembly occurs in the presence of histone
chaperones and ATP-dependent remodelling complexes. Further-
more, it is performed at physiological ionic strengths and allows
the production of regularly spaced nucleosomal arrays [35]. In
addition, since Drosophila has no endogenous TRF2, purified TRF2
can be added to Drosophila embryonic extracts to evaluate the
impact of the protein on nucleosome assembly.
In our in vitro nucleosome assembly experiments, we used a
construct in which the 601 DNA sequence was placed directly
upstream of a 1.7-kbp human telomeric sequence. The 601 DNA
is a 147 bp DNA with the highest affinity for the histone octamer
known to date [36]. Since telomeric nucleosomes occupy multiple
positions [37] and spontaneously slide along DNA [38], the
presence of a well-positioned nucleosome represents a precise
starting point to map nucleosome organization on telomeric
sequences. The 601/telomere DNA construct was terminally
labelled upstream of the 601 DNA sequence and the nucleosomal
array assembled in vitro using a Drosophila embryonic extract.
Nucleosome positioning relative to the end of the fragment was
monitored by digestion with MNase and separation of the
resultant DNA fragments on an agarose gel. A nucleosomal
assembly reaction onto the 601/telomere DNA construct is shown
in Figure 4A. Digestion of the assembled nucleosomal arrays with
MNase yielded a nucleosomal ladder with a spacing of
approximately 155 bp, consistent with the nucleosome spacing
found in vivo at telomeres [10–12]. In comparison, MNase
digestion of a nucleosomal array assembled on a 1,600-bp DNA
fragment containing eight tandem 200-bp repeats of the 601 DNA
yielded a regular 200 bp nucleosome spacing (Figure 4B). These
data strongly suggest that the tight nucleosome spacing found at
telomeres is a sequence-dependent phenomenon specific to
telomeric chromatin. To further exclude the possibility that the
short telomeric nucleosome spacing observed is an artefact of our
experimental conditions, we used the Drosophila extracts to form
nucleosomal arrays on a non-repetitive DNA sequence, namely a
linearized pUC18 plasmid containing only one 601 repeat at the
end of the fragment (Figure S3). Also in this case MNase digestion
revealed a nucleosome spacing of about 200 bp.
Next, we analyzed whether TRF2 could affect nucleosome
assembly on telomeric DNA. When nucleosomal arrays were
assembled in the presence of TRF2, the distance between
telomeric nucleosomes increased and became less regular
(Figure 4C). In particular, the increase in spacing seems directly
related with nucleosome distance from the 601 sequence. The
addition of a non-specific protein such as bovin serum albumin
does not modify telomeric internucleosomal distances (Fig. S4),
supporting the hypothesis that the increase in nucleosome spacing
is due to the specific binding of TRF2 to telomeric DNA and not
to non-specific effects. The in vitro chromatin assembly data are
consistent with the results of MNase digestion analyses performed
on cells overexpressing TRF2 (Figure 2) [23], and support a highly
dynamic view of human telomeric chromatin.
Discussion
This work demonstrates that TRF2 is capable to modify
nucleosome organization both in vitro and in vivo. Chromatin
immunoprecipitation experiments reveal an inverse correlation
between TRF2 dosage and nucleosomes at telomeres of cancer
cells (Figure 1). The number of detected telomeric nucleosomes
increases in TRF2-depleted cells, while less telomeric nucleosomes
are observed in TRF2-overexpressing cells. These data suggest
that TRF2 reduces either the accessibility to anti-histone
antibodies or the amount of nucleosomes or both. However, in
TRF2 overexpressing cells nucleosome spacing at telomeres
increases and the telomeric chromatin appears more accessible
to MNase (Figure 2); this data argue against a model where TRF2
reduces the accessibility of telomeric chromatin favouring the
alternative possibility, i.e. that TRF2 reduces nucleosome density
at telomeres. These results are in agreement with previous results
in mice showing that TRF2 overexpression decreases the levels of
histones H3 and H4 and increases nucleosome spacing at
telomeres [23]. In addition, the current study reveals several
new key points. First, nucleosome reorganization is a short-term
effect of TRF2 binding and does not correlate with changes in
telomere length. We further showed that the incorporation of
TRF2 at telomeres in G1/S cells does not trigger nucleosome
reorganization, while passage through S/G2/M does. Important-
ly, the ability of TRF2 to alter nucleosome organization is
supported by in vitro chromatin assembly experiments using
Drosophila embryonic extracts that are devoid of shelterin
TRF2 Controls Telomeric Nucleosome Organization
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components. In the absence of TRF2, the distance between
telomeric nucleosomes reproduces the short spacing found in vivo
[10,11], suggesting that this could be an intrinsic characteristic of
telomeric sequences. When TRF2 is added during the assembly,
nucleosome spacing increases and becomes irregular, indicating
that TRF2 possesses the intrinsic ability to change nucleosome
organization.
Several non-exclusive mechanisms could explain how TRF2
reduces nucleosome density at telomeres. First, TRF2 binding
could displace histone octamers (Figure 5A). However, this
hypothesis appears unlikely since: i) the incorporation of TRF2
Figure 3. Cell-cycle regulation of TRF2-mediated telomeric remodelling. (A) Scheme of the synchronization experiment (see Materials and
Methods for details). (B) ChIP of C33A cells overexpressing TRF2FL and control C33A cells using the indicated antibodies and hybridized with Telo and
Alu probes. From the left: slot-blots in asynchronous control cells; at the G1/S boundary; 5 hours after release from thymidine block; 12 hours after
release; cells maintained in thymidine block for 12 additional hours (12 h+Th). (C) Quantifications of the data in (B) expressed as Telo/Alu
hybridization signals. Error bars are s.d. of three independent experiments. Asterisks, p,0.05 based on unpaired Student’s t-test.
doi:10.1371/journal.pone.0034386.g003
TRF2 Controls Telomeric Nucleosome Organization
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at telomeres in G1/S cells do not trigger apparent nucleosome
displacement; ii) both TRF1 and TRF2 are unable to dissociate
nucleosomes in vitro, even at a high protein/nucleosome ratio [39]
(A. Galati, M. Savino, S. Cacchione, unpublished data), despite
the fact that telomeric nucleosomes are less stable than bulk
nucleosomes [40]; addition of TRF2 to reconstituted telomeric
nucleosome arrays causes chromatin compaction but no apparent
dissociation of histones [33] iii) TRF2 has a very low affinity for
Figure 4. TRF2-regulated in vitro chromatin assembly on human telomeric DNA. (A) MNase digestion of chromatin assembled on the 601/
telomere DNA fragment. Lane 1, labelled 100 bp DNA ladder; lane 2 to 5, assembled chromatin digested respectively with 0, 2, 10, 60 U/ml of MNase.
A schematic drawing of the DNA fragment and of the nucleosomal positioning and spacing is represented on the right. (B) MNase digestion of
chromatin assembled on the 601-2008 DNA fragment. Lane 1, labelled 100 bp DNA ladder; lane 2 to 3, assembled chromatin digested with MNase. (C)
Chromatin assembly in the absence and in the presence of TRF2. Lane 1, labelled 100 bp DNA ladder; lane 2, assembled chromatin digested with
10 U/ml of MNase; lane 3, chromatin assembled in the presence of 100 nM TRF2 digested with 10 U/ml of MNase; lane 4, chromatin assembled in the
presence of 200 nM TRF2 digested with 10 U/ml of MNase.
doi:10.1371/journal.pone.0034386.g004
TRF2 Controls Telomeric Nucleosome Organization
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nucleosomal telomeric binding sites (A. Galati, M. Savino, S.
Cacchione, unpublished data), which makes TRF2 different from
other telomeric proteins such as hTRF1 [39] and yeast Rap1 [41].
Second, TRF2 may bind between nucleosomes, interacting with
nucleosome borders, thereby increasing their spacing (Figure 5B).
This may result from an enhancement of the intrinsic mobility of
telomeric nucleosomes [38]. This mechanism has been recently
proposed to explain TRF1-induced nucleosome mobility in vitro
[42]. Third, TRF2 could act by recruiting ATP-dependent
remodeling complexes to telomeres that could mediate nucleo-
some sliding and/or disruption (Figure 5C). Fourth, TRF2 could
compete with histones for DNA binding during nucleosome
assembly (Figure 5D). In favour of this hypothesis, TRF2 wraps
DNA around itself in a right-handed orientation [43–45]. This
could disfavour nucleosome formation at or in the close proximity
of TRF2-DNA complexes by imposing torsional constrains.
The TRF2-mediated chromatin changes will undoubtedly
deserve further investigation. Considering that altered TRF2
expression levels result in telomere dysfunction and instability, a
tempting hypothesis is that TRF2 regulation of nucleosome
density is an important factor in the establishment of a protective
telomere structure. It is worth noting that another telomeric
protein, yeast Rap1, forms a nucleosome-free region at telomeres
[5]; interestingly, in the case of yeast Rap1, the effect on chromatin
organization can also be observed outside telomeres: nucleosome
occupancy at several yeast promoters containing Rap1 sites was
also shown to be reduced [46,47]. Thus, the chromatin
modulation controlled by TRF2 might also be involved in the
regulation of expression of a network of genes located throughout
the genome [48,49]. This would provide a mechanistic link
between a telomere’s functional state and cellular transcriptional
programs.
Materials and Methods
Cell culture and synchronization
Human cell lines C33A (carcinoma, cervix), human fibrosarco-
ma HT1080 and kidney cell line 293 T were maintained in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with
10% fetal calf serum (FCS) and 100 U/ml penicillin plus 100 mg/
ml streptomycin.
To synchronize the human C33A cells at the G1/S boundary,
double-thymidine block was performed. Cells were arrested with
2 mM thymidine for 14 h, and then released to fresh medium for
10 h followed by second treatment of 2 mM thymidine for 14 h.
Lentivirus production
Lentivirus for the transfection was prepared essentially as
described [50]. 8,6 mg of VSVg-pseudotyped self inactivating
(SIN) lentiviruses, expressing empty vector, TRF2FL, or
TRF2DBDM, 8.6 mg of Lenti-Delta 8.91 and 2.8 mg of VSV-g
were introduced into 56106 T293 cells in DMEM, supplemented
with 10% Fetal Calf Serum at 37u in 5% CO2 in 10 cm dish,
through calcium phosphate mediated transfection. Virus contain-
ing supernatants were collected after 48 and 72 hours, passed
through a 0.45 mm Millipore filter and used to infect C33A and
Figure 5. Models for TRF2-induced remodeling of telomeric chromatin. See the text for details.
doi:10.1371/journal.pone.0034386.g005
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HT1080 cells. The efficiency of infection was determined by flow
cytometry analysis of GFP expression.
Cell cycle analysis
DNA content and bromodeoxyuridine (BrdU) incorporation
were determined by flow cytometry (Coulter Epix XL). Briefly,
30 min before harvesting, 45 mM BrdU was added to the culture
medium. Cells were then fixed in a 1:1 methanol: PBS mixture
and DNA was denaturated in 3 N HCl for 60 min. After
neutralizing in 0.1 M sodium tetraborate, cells were incubated
with a mouse monoclonal anti-BrdU antibody (Becton &
Dickinson) for 1 h at room temperature, washed in PBS+0.5%
Tween-20 and then incubated for 45 min with Alexa Fluor 488-
conjugated anti mouse antibody (Molecular Probes, Eugene, OR).
After extensive washing, cells were resuspended in PBS containing
10 mg/ml propidium iodide and analysed for their DNA content
(red fluorescence) and BrdU incorporation (green fluorescence).
Ten thousand events were collected for each sample. DNA
histograms and biparametric dot plots of DNA and BrdU content
were obtained using WinMDI software.
Chromatin immunoprecipitation assays (ChIP)
For ChIPs, 36106 cells were fixed in 1% formaldehyde for
15 min at RT on a shaking platform. Cross-linked cells were
washed twice with cold PBS, scraped and lysed at a density of
206106 cells/ml for 10 min at 4uC in 1% SDS, 50 mM Tris-HCl
(pH 8.0) and 10 mM EDTA. Lysates were sonicated to obtain
chromatin fragments ,1 kb and centrifuged for 15 min in a
microfuge at RT. Chromatin was diluted 1:10 with 1.1% Triton-
X100, 2 mM EDTA, 150 mM NaCl and 20 mM Tris-HCl
(pH 8.0) and precleared with a 50% salmon sperm DNA/protein
A agarose slurry (Millipore). Chromatin fragments were incubated
with one of the following antibodies at 4uC overnight on a rotating
platform: 5 mg of anti-H2A (Abcam), anti-H2B (Abcam), rabbit
polyclonal anti-Histone H3 (Millipore), 10 mg of monoclonal anti-
TRF2 (Imgenex), and 1 mg IgG (SIGMA). Salmon sperm DNA/
protein Agarose beads (60 ml) were then added and the incubation
continued for 1 hour. Immunoprecipitated pellets were washed
with 0.1% SDS, 1% Triton-X100, 2 mM EDTA, 20 mM Tris-
HCl (pH8.0) and 150 mM NaCl (one wash); 0.1% SDS, 1%
Triton-X100, 2 mM EDTA, 20 mM Tris-HCl (pH 8.0) and
500 mM NaCl (one wash); 0.25 M LiCl, 1% Nonidet P-40, 1%
sodium deoxycholate, 1 mM EDTA and 10 mM Tris-HCl,
pH 8.0 (one wash); and 10 mM Tris-HCl (pH 8.0) and 1 mM
EDTA (two washes). Chromatin was eluted from the beads with
250 ml 1% SDS and 0.1 M NaHCO3. After adding 20 ml of 5 M
NaCl, crosslinks were reversed for 4 h at 65uC. Samples were
supplemented with 20 ml of 1 M Tris-HCl (pH 6.5), 10 ml of
0.5 M EDTA, 20 mg of RNase A and 40 mg of proteinase K and
incubated for 1 h at 45uC. DNA was then recovered by phenol/
chloroform extraction and ethanol precipitation, slot-blotted onto
a Hybond N+ membrane and hybridized with a telomeric probe
or Alu probe labeled by random priming. Filters were scanned
with Typhoon 9200 phosphoimager (GE Healthcare). The
quantification of the signal was done using the ImageQuant
software. For total DNA samples, aliquots corresponding to 1/10
dilution of the amount of lysate used in the immunoprecipitation
were processed along with the rest of the samples at the step of
reversing the crosslinks. We calculated the amount of telomeric or
centromeric DNA immunoprecipitated in each ChIP using the
ratio between the immunoprecipitated fraction and the corre-
sponding total DNA sample (Input).
Telomere length measurements
For TRF determination, 15 mg of DNA were digested with
restriction enzymes Hinf I (10 U) and Rsa I (10 U; Roche), and
electrophoresed on 0.8% agarose gel. Then, DNA was denatured,
neutralized, transferred to a nylon membrane (Hybond N,
Amersham International, Buckinghamshire, UK) and cross-linked
with ultraviolet light. The membrane was hybridized with 50-end
[c-32P]deoxyadenosine triphosphate labeled telomeric oligonucle-
otide probe (TTAGGG)4 at 42uC for 2 h in a rapid hybridization
buffer (QuikHyb Hybridization Solution, Stratagene, La Jolla,
USA). After washing, the filters were autoradiographed (Hyper-
film-MP; Amersham) with an intensifying screen at 280uC for
24 h and the autoradiographs were scanned and the mean
telomere length calculated.
Micrococcal nuclease digestion of nuclei
Nuclei were isolated and digested with micrococcal nuclease
(MNase) as described [11]. Briefly, cells were trypsinized,
suspended in growth medium, and harvested by centrifugation
at 1,500 rpm for 5 min. Cells were suspended at 26106 cells/ml in
buffer A (100 mM KCl, 10 mM Tris [pH 7.5], 3 mM MgCl2,
1 mM CaCl2, 0.5 mM PMSF), washed twice with buffer A, then
resuspended at 56106 cells/ml in buffer A with 0.6% Nonidet P-
40 to lyse cells. After gentle mixing and incubation on ice for
5 min, nuclei were harvested at 2,000 rpm for 5 min and
resuspended in buffer A without NP-40 at 2.56107 cells/ml. Cells
were homogenized in a dounce homogenizer using a tight B-type
pestle. Aliquots of 150 ml were digested for 5 min at 30uC with
MNase (Worthington) at concentrations ranging from 25 to
500 U/ml. Reactions were stopped by adding one volume of
TEES/proteinase K (10 mM Tris HCl [pH 7.5], 10 mM EDTA,
10 mM EGTA, 1% SDS, 50 mg/ml proteinase K) and incubated
at 37uC from 2 hours to overnight. DNA was extracted with
phenol/chloroform, precipitated with isopropanol in the presence
of 0.2 M sodium acetate (pH 5.5), and resuspended in 500 mL TE
(10 mM Tris, 1 mM EDTA, pH 8.0). Samples were run on 1.5%
agarose gels, transferred to a nylon membrane and hybridized
sequentially with a telomeric probe and with an Alu probe. Filters
were scanned with Typhoon 9200 phosphoimager (GE Health-
care) and images analyzed with Imagequant software and
corrected using median local background subtraction.
Plasmids
The plasmid pUC18/601-2008 was a kind gift from D. Rhodes.
To obtain the 601/Telomere construct, a 601 monomer was
extracted from the pUC18/601-2008 plasmid by cutting with the
AvaI restriction enzyme. The DNA fragment was then ligated to
two adapters containing the BamHI restriction site (Adapter I: 59-
GCCGATGGATCCTATGTCAC-39, 59-CCGAGTGACA-
TAGGATCCATCGGC-39; Adapter II: 59-TCGGGTTCAAGG-
GATCCGCATCC-39, 59-GGATGCGGATCCCTTGAAC-39).
The construct was digested with BamHI and inserted in the
BamHI site of the pCMV-Telo plasmid [17] upstream of the
1700 bp of TTAGGG repeats.
Protein purification
6xHis -tagged TRF2 was expressed in BL21(D3) cells and
purified as previously described [43]. Briefly, supernatant from a
cell lysate was bound to Ni-NTA slurry (Qiagen). After several
washes with Wash Buffer (50 mM Hepes [pH8], 10 mM b-
mercaptoethanol, 500 mM KCl, 20 mM Imidazole, 1 mM
PMSF, 10% Glycerol), the protein was eluted with the same
buffer containing 300 mM Imidazole and dialyzed against Wash
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Buffer. Protein concentration was assessed by Bradford assay
(SIGMA). A SDS-PAGE gel of the purified protein is shown in
Figure S5.
Chromatin assembly and micrococcal nuclease analysis
The pCMV-601Telo plasmid was digested with Alw44I and the
resulting 4400 bp DNA fragment was gel purified and biotinylated
by filling in with klenow enzyme and biotin-11-dUTP (Fermentas).
The biotinylated fragment was then digested with Bsp1407I to
generate a fragment of about 2000 bp, which was gel-purified and
terminally labelled by filling in with klenow enzyme and
[a-32P]dATP. The 601-2008 DNA sequence was prepared by
digesting the pUC18/601-2008 plasmid with XbaI and biotiny-
lated as described above. The biotinylated plasmid was then
digested with EcoRI, gel-purified and labeled by filling in with the
klenow enzyme and [a-32P]dATP.
For the assembly reaction 1 mg of labelled DNA was bound to
Dynabeads streptavidin M-280 (Dynal) and then assembled with
Drosophila embryo extracts essentially as described [35]. To the
DNA, we added 40 ml embryo extract, 40 ml EX buffer (10 mM
Hepes-KOH (pH 7.6), 1.5 mM MgCl2, 80 mM KCl, 0.5 mM
EGTA, 10% glycerol, 10 mM b-glycerophosphate, 1 mM DTT,
0.05% NP40), 10 ml of an energy-regenerating-system (300 mM
creatine phosphate, 10 mg/ml creatine kinase, 30 mM MgCl2,
10 mM DTT, 30 mM ATP pH 8), to reach a total volume of
100 ml. After 6 to 8 hours of assembly at 26uC, chromatin was
digested for 1 min with MNase at 2–60 U/ml concentrations.
Reactions were stopped by adding one volume of TEES/
proteinase K (10 mM Tris HCl pH 7.5, 10 mM EDTA, 10 mM
EGTA, 1% SDS, 50 mg/ml proteinase K) and incubated at 37uC
for 2 hours. DNA was phenol-extracted and run on a 1.5%
agarose gel.
Supporting Information
Figure S1 TRF2 alters nucleosomal organization in
HT1080 fibrosarcoma cells. (A) ChIP of HT1080 cells
overexpressing TRF2FL or TRF2DBDM and of control HT1080
cells using the indicated antibodies. Slot-blots were hybridized
with a labelled Telo repeat probe and an Alu probe. (B)
Quantification of the data in (A) expressed as probe/input
hybridization signals. Error bars are s.d. of three independent
experiments. Asterisks, p,0.05 based on unpaired Student’s t-test.
(TIF)
Figure S2 The influence of TRF2 on nucleosome
organization does not derive from telomere shortening.
(A) Terminal restriction fragment length measured by Southern
Blot in C33A cells infected with an empty vector, with TRF2FL or
TRF2DBDM hybridized with the telomeric probe (TTAGGG)4. (B)
Quantification of the data in (A) expressed as mean telomere
length. (C) Terminal restriction fragment length measured by
Southern Blot in HT1080 cells infected with an empty vector, with
TRF2FL or TRF2DBDM hybridized with the telomeric probe
(TTAGGG)4. (D) Quantification of the data in (C) expressed as
mean telomere length.
(TIF)
Figure S3 Chromatin assembly on non-repetitive DNA
sequence. MNase digestion of chromatin assembled on the
linearized pUC18/601 plasmid. Lane 1, labelled 100 bp DNA
ladder; lane 2, assembled chromatin digested with 60 U/ml of
MNase. A schematic drawing of the DNA fragment and of the
nucleosomal positioning and spacing is represented on the right.
(TIF)
Figure S4 Non-specific proteins do not alter nucleo-
some spacing at telomeres in in vitro chromatin
assembly. MNase digestion of chromatin assembled on the
601/telomere DNA fragment. Lane 1, labelled 100 bp DNA
ladder; lane 2, assembled chromatin digested with 60 U/ml of
MNase; lane 3, assembled chromatin digested with 60 U/ml of
MNase in the presence of 200 nM BSA.
(TIF)
Figure S5 Gel analysis of recombinant TRF2 protein.
SDS-page gel analysis of the TRF2 protein after purification. Lane
1, protein ladder; lane 2–3, TRF2 protein, 0.5 mg and 4 mg
respectively.
(TIF)
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